Vertex Pharmaceuticals (NASDAQ: VRTX) and AstraZeneca (NASDAQ: AZN), two of the world's leading drugmakers, missed last ...

For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).

This article reviews the usefulness of the electrodiagnostic examination in patients who have suspected cervical and lumbosacral radiculopathy. This study can verify the presence and severity of ...

The U.S. Food and Drug Administration approved twice-daily JOURNAVX for the treatment of adults with moderate-to-severe acute pain. Vertex has established a wholesale ... to advance its pivotal ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

It plans to progress its pivotal programme evaluating the therapy for painful lumbosacral radiculopathy ... opportunity to change the paradigm of acute pain management and establish a new standard ...

It plans to progress its pivotal programme evaluating the therapy for painful lumbosacral radiculopathy, pending regulatory discussions ... we have the opportunity to change the paradigm of acute pain ...

cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain ? and continues to advance clinical and research ... and plans to advance the pivotal program evaluating ...

Astronauts commonly reported acute and chronic pain during and after spaceflight, particularly in the lumbar spine. During and after spaceflight, astronauts experience lower back pain (LBP ...

Acute renal failure is caused by damage to the kidneys, which can occur as a result of blood loss, toxins, or physical damage to the kidneys. Acute renal failure occurs rapidly, causing generalized ...

A lumbar puncture (spinal tap) is a common test doctors use to check for signs of MS in your spinal fluid. But a lumbar puncture on its own isn’t enough to confirm an MS diagnosis. Diagnosing ...